ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.61
0.20%
US Tech 100
18,138.40
1.69%
S&P 500
5,308.15
1.17%
US Dollar vs CAD
1.36176
0.15%
Bitcoin
66,012.37
-0.37%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AngioDynamics Inc (ANGO)

  7. AngioDynamics Inc (ANGO) News

ANGO

AngioDynamics (ANGO)

AngioDynamics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANGO
DateTimeSourceHeadlineSymbolCompany
05/06/20243:45PMBusiness WireAngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific SessionsNASDAQ:ANGOAngioDynamics Inc
04/04/20246:31AMIH Market NewsUS Index Futures Rise, Oil Dips SlightlyNASDAQ:ANGOAngioDynamics Inc
04/04/20246:00AMBusiness WireAngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset DivestitureNASDAQ:ANGOAngioDynamics Inc
04/04/20245:45AMBusiness WireAngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PENASDAQ:ANGOAngioDynamics Inc
04/01/20244:26PMBusiness WireAngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.NASDAQ:ANGOAngioDynamics Inc
03/19/20243:01PMBusiness WireAngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024NASDAQ:ANGOAngioDynamics Inc
03/06/20243:01PMBusiness WireAngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services ConferenceNASDAQ:ANGOAngioDynamics Inc
03/04/20247:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
02/15/20243:05PMBusiness WireAngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 MillionNASDAQ:ANGOAngioDynamics Inc
01/23/20243:14PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANGOAngioDynamics Inc
01/23/20247:00AMBusiness WireAngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial DiseaseNASDAQ:ANGOAngioDynamics Inc
01/22/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGOAngioDynamics Inc
01/11/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGOAngioDynamics Inc
01/08/20243:47PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGOAngioDynamics Inc
01/05/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGOAngioDynamics Inc
01/05/20246:00AMBusiness WireAngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 GuidanceNASDAQ:ANGOAngioDynamics Inc
12/21/20233:01PMBusiness WireAngioDynamics to Present at the J.P. Morgan Healthcare ConferenceNASDAQ:ANGOAngioDynamics Inc
12/07/20233:01PMBusiness WireAngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024NASDAQ:ANGOAngioDynamics Inc
12/07/20237:00AMBusiness WireAngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary EmbolismNASDAQ:ANGOAngioDynamics Inc
11/07/20237:03AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ANGOAngioDynamics Inc
10/06/20231:34PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANGOAngioDynamics Inc
10/05/20234:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGOAngioDynamics Inc
10/04/20236:22AMIH Market NewsWednesday’s Wall Street Highlights: Apple, Intel, Cal-Maine, A10 Networks, and moreNASDAQ:ANGOAngioDynamics Inc
10/04/20236:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGOAngioDynamics Inc
10/04/20236:00AMBusiness WireAngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 GuidanceNASDAQ:ANGOAngioDynamics Inc
09/21/20238:28PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ANGOAngioDynamics Inc
09/21/20238:23PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ANGOAngioDynamics Inc
09/21/20238:17PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ANGOAngioDynamics Inc
09/21/20238:12PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ANGOAngioDynamics Inc
09/21/20238:07PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ANGOAngioDynamics Inc
 Showing the most relevant articles for your search:NASDAQ:ANGO

Your Recent History

EU
V153S
V153S
CSE
ZBR
Zanzibar Gold
TSXV
CAW.P
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved